SP
GILD icon

SWS Partners’s Gilead Sciences GILD Stock Holding History

SWS Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-70
Closed -$4.8K – 181
2024
Q2 		$4.8K Buy
+70
New +$4.67K ﹤0.01% 293
2018
Q2 		– Sell
-1,539
Closed -$113K – 178
2018
Q1 		$113K Buy
1,539
+218
+17% +$17.3K 0.08% 89
2017
Q4 		$95K Buy
+1,321
New +$100K 0.07% 95

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

SWS Partners's GILD Position: Q3 2024 in Review

SWS Partners sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 70 shares — an estimated $4.8K sold.

SWS Partners first reported a position in GILD in Q4 2017 and held it in 3 quarters. The position peaked at $113K in Q1 2018. 1,718 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • SWS Partners reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • SWS Partners sold 70 Gilead Sciences shares in Q3 2024, an estimated $4.8K.
  • SWS Partners first reported a position in Gilead Sciences in Q4 2017 and held it in 3 quarters.
  • SWS Partners's Gilead Sciences position peaked at $113K in Q1 2018.
  • 1,718 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on SWS Partners's 13F filing for Q3 2024, filed 15 Oct 2024.